Eosinophilic Asthma
📧 Sign up to get email alerts when something new happens for Eosinophilic Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab [Phase 4]
Phase 4 trial update evaluating whether reducing daily ICS/LABA maintenance to an anti-inflammatory reliever approach is feasible in severe …
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Real World Evidence of Benralizumab in Eosinophilic Severe AsThma in Russia (BEST)
This is a real-world evidence update on benralizumab for severe eosinophilic asthma in Russia (BEST), based on a completed study.
-
FDA approval · 2024-09-17FDA Approved: FASENRA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for FASENRA (benralizumab) from AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2024-07-01Clinical Trial Update: Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.
This clinical trial update reports patient-reported outcomes from a completed study of benralizumab in adults with severe eosinophilic asthm…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Asthma Control in a Dutch Primary Care Population
Completed clinical trial evaluating asthma control in a Dutch primary care population. The provided snippet does not include results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Predictive Signature of Benralizumab Response [Phase 4]
A Phase 4 clinical trial is evaluating a predictive biomarker signature for benralizumab response in eosinophilic asthma with severe feature…
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: BenRalizumab Effect on Airway Remodeling in Severe asTHma [Phase 4]
Phase 4 clinical trial evaluating benralizumab's effect on airway remodeling in severe asthma with eosinophilic features; recruiting.
-
CLINICAL_TRIALS trial_result · 2024-01-25Clinical Trial Update: Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma [Phase 4]
Phase 4 trial evaluating dose escalation of reslizumab in patients with severe eosinophilic asthma.
-
CLINICAL_TRIALS trial_result · 2023-08-16Clinical Trial Update: Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma [Phase 2]
A Phase 2 proof-of-concept study evaluating Etokimab (ANB020) in adults with severe eosinophilic asthma has completed, with results posted i…
-
CLINICAL_TRIALS trial_result · 2023-05-18Clinical Trial Update: PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma [Phase 3]
Phase 3 trial update assessing benralizumab in children with severe eosinophilic asthma, focusing on PK/PD and long-term safety.
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma [Phase 3]
Phase 3 trial update for CHF 6532 in uncontrolled severe eosinophilic asthma; study terminated.
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma [Phase 2]
Phase 2 dose-ranging biomarker study of dexpramipexole in eosinophilic asthma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab". [Phase 4]
Phase 4 trial comparing efficacy of Mepolizumab versus Omalizumab in severe asthma (Choosebetweenamab). Status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in Brazil [Phase 4]
A Phase 4 pragmatic study evaluating the efficacy and safety of mepolizumab for severe uncontrolled asthma in Brazil.
-
FDA approval · 2019-10-03FDA Approved: FASENRA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for FASENRA (benralizumab) from AstraZeneca, updating its labeling and/or indications.
-
FDA approval · 2019-09-12FDA Approved: NUCALA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for NUCALA (mepolizumab) submitted by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2019-08-29Clinical Trial Update: Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma [Phase 2]
Phase 2 trial update on OC000459 for eosinophilic airway inflammation in severe asthma has completed.
-
FDA approval · 2019-06-06FDA Approved: NUCALA — Original Application (GlaxoSmithKline LLC)
FDA approves the original application for NUCALA (mepolizumab) by GlaxoSmithKline, for add-on maintenance treatment in patients with severe …
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma [Phase 3]
Phase 3 trial update for reslizumab in severe eosinophilic asthma in patients aged 12 and older; study terminated with results posted in 201…
-
FDA approval · 2019-01-09FDA Approved: CINQAIR — Supplemental Application (Teva Respiratory, LLC)
FDA approved a supplemental application for CINQAIR (reslizumab) submitted by Teva Respiratory, LLC.
-
CLINICAL_TRIALS trial_result · 2018-08-29Clinical Trial Update: Impact of Benralizumab Treatment on Circulating Dendritic Cells in Patients With Eosinophilic Asthma [Phase 4]
Phase 4 trial update studying the impact of benralizumab on circulating dendritic cells in patients with severe eosinophilic asthma.
-
FDA approval · 2017-11-14FDA Approved: FASENRA — Original Application (AstraZeneca Pharmaceuticals LP)
The FDA granted original approval to FASENRA (benralizumab) from AstraZeneca as a treatment for adults with severe eosinophilic asthma. This…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma [Phase 3]
Phase 3 trial evaluating reslizumab for eosinophilic asthma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma [Phase 3]
Phase 3 trial evaluating reslizumab for reducing asthma exacerbations in eosinophilic asthma completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-06-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma [Phase 3]
Phase 3 trial evaluating reslizumab at 0.3 or 3.0 mg/kg for eosinophilic asthma has been completed with results posted.